Operator and Institutional Requirements for Transcatheter Mitral Valve Therapies in Australia: a CSANZ and ANZSCTS Position Statement

David W.M. Muller, Aubrey Almeida, Anthony Camuglia, Darren Walters, Jurgen Passage, Gregory M. Scalia, Ravinay Bhindi, Sidney Lo, Jayme Bennetts, Antony Walton, on behalf of Cardiac Society of Australia and New Zealand (CSANZ) and Australia and New Zealand Society of Cardiac and Thoracic Surgery (ANZSCTS)

Research output: Contribution to journalArticleOtherpeer-review

2 Citations (Scopus)


This expert Position Statement is a description of the requirements for Accreditation for transcatheter mitral valve therapy (TMVT) in Australia. The requirements include the need for a multidisciplinary Heart Team review of individual cases, mandatory reporting of outcome data to a national TMVT Registry, and accreditation of individuals and institutions by the Conjoint Accreditation Committee, the assigned accreditation authority.

Original languageEnglish
Pages (from-to)1805-1810
Number of pages6
JournalHeart Lung and Circulation
Issue number12
Publication statusPublished - Dec 2021
Externally publishedYes


  • Heart failure
  • Mitral regurgitation
  • Transcatheter mitral valve therapy

Cite this